Remdesivir and GS-441524

被引：0
|
作者：
Yan, Victoria
机构：
来源：
CHEMICAL & ENGINEERING NEWS | 2021年 / 99卷 / 23期
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [21] Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment
    Jiashu Xie
    Zhengqiang Wang
    Acta Pharmaceutica Sinica B, 2021, 11 (06) : 1607 - 1616
  • [22] Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19
    Tempestilli, Massimo
    Caputi, Priscilla
    Avataneo, Valeria
    Notari, Stefanie
    Forini, Olinda
    Scorzolini, Laura
    Marchioni, Luisa
    Bartoli, Tommaso Ascoli
    Castilletti, Concetta
    Lalle, Eleanore
    Capobianchi, Maria R.
    Nicastri, Emanuele
    D'Avolio, Antonio
    Ippolito, Giuseppe
    Agrati, Chiara
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (10) : 2977 - 2980
  • [23] Structural Insights into Plasticity and Discovery of Remdesivir Metabolite GS-441524 Binding in SARS-CoV-2 Macrodomain
    Ni, Xiaomin
    Schroeder, Martin
    Olieric, Vincent
    Sharpe, May E.
    Hernandez-Olmos, Victor
    Proschak, Ewgenij
    Merk, Daniel
    Knapp, Stefan
    Chaikuad, Apirat
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (04): : 603 - 609
  • [24] Removal of Remdesivir's Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19
    Le, Minh Patrick
    Le Hingrat, Quentin
    Jaquet, Pierre
    Wicky, Paul-Henri
    Bunel, Vincent
    Massias, Laurent
    Visseaux, Benoit
    Messika, Jonathan
    Descamps, Diane
    Mal, Herve
    Timsit, Jean-Francois
    Peytavin, Gilles
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (11)
  • [25] First analytical confirmation of drug-induced crystal nephropathy in felines caused by GS-441524, the active metabolite of Remdesivir
    Furbish, Amelia
    Allinder, Marissa
    Austin, Glenn
    Tynan, Beth
    Byrd, Emilee
    Gomez, Ivette Pina
    Peterson, Yuri
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2024, 247
  • [26] Population pharmacokinetic modeling of GS-441524, the active metabolite of remdesivir, in Japanese COVID-19 patients with renal dysfunction
    Sukeishi, Asami
    Itohara, Kotaro
    Yonezawa, Atsushi
    Sato, Yuki
    Matsumura, Katsuyuki
    Katada, Yoshiki
    Nakagawa, Takayuki
    Hamada, Satoshi
    Tanabe, Naoya
    Imoto, Eishi
    Kai, Shinichi
    Hirai, Toyohiro
    Yanagita, Motoko
    Ohtsuru, Shigeru
    Terada, Tomohiro
    Ito, Isao
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2022, 11 (01): : 94 - 103
  • [27] The Potential Protective Role of GS-441524, a Metabolite of the Prodrug Remdesivir, in Vaccine Breakthrough SARS-CoV-2 Infections
    JiaYi Zhu
    Yuchong Li
    Jady Liang
    Samira Mubareka
    Arthur S. Slutsky
    Haibo Zhang
    Intensive Care Research, 2022, 2 (3-4): : 49 - 60
  • [28] Thirty-two cats with effusive or non-effusive feline infectious peritonitis treated with a combination of remdesivir and GS-441524
    Green, Jodie
    Syme, Harriet
    Tayler, Sarah
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2023, 37 (05) : 1784 - 1793
  • [29] Development and Validation of a Simple and Selective HPLC-MS/MS Method for Simultaneous Quantification of GS-441524 and its Prodrug Remdesivir
    Guan, Su
    Tu, Meijuan
    Evans, Samantha
    Yu, Aiming
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [30] Predictive factors associated with short-term mortality in cats with feline infectious peritonitis treated with remdesivir or GS-441524 or both
    Goto, Sho
    Kamiyoshi, Tsuyoshi
    Iwasaki, Ryota
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2025, 39 (01)
12345